|
|
Volumn 37, Issue 12, 2001, Pages 823-828
|
|
Chemotherapy Foundation Symposium XIX: Innovative cancer therapy for tomorrow
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 AZA 2' DEOXYCYTIDINE;
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
BORTEZOMIB;
CA 125 ANTIGEN;
CAPECITABINE;
CHELATING AGENT;
CLARITHROMYCIN;
COMPLEMENTARY DNA;
CYANOCOBALAMIN;
CYTARABINE;
DEXAMETHASONE;
DOCETAXEL;
FLUDARABINE;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
GEMCITABINE;
IBRITUMOMAB TIUXETAN;
IMATINIB;
INTERFERON;
IROFULVEN;
OXALIPLATIN;
PEMETREXED;
PENTOSTATIN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
THALIDOMIDE;
TOPOTECAN;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
COLON CANCER;
CONFERENCE PAPER;
DIARRHEA;
ENZYME ACTIVITY;
FEBRILE NEUTROPENIA;
FLUORESCENCE IN SITU HYBRIDIZATION;
GASTROINTESTINAL TOXICITY;
HAND FOOT SYNDROME;
HUMAN;
IMMUNE DEFICIENCY;
MEDICAL SOCIETY;
MOLECULAR DYNAMICS;
NEUTROPENIA;
OVARY CANCER;
PANCREAS CANCER;
UNITED STATES;
VITAMIN SUPPLEMENTATION;
|
|
EID: 0035701740
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.2001.37.12.662112 Document Type: Conference Paper |
|
Times cited : (1)
|
|
References (0)
|
